Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Statistics in Medicine have announced the dates in 2015 when they will run this ever popular course.

Logo for the Centre for Statistics in Medicine.

RANDOMISED CONTROLLED TRIAL COURSE: A Guide to Design, Conduct, Analysis, Interpretation and Reporting

21st September – 25th September 2015

Pembroke College, Oxford

About the course:

This course provides a thorough grounding in the principles and practice of randomised controlled trials (RCTs) for the evaluation of healthcare interventions. It will include talks and practicals to give examples and guidance on the methodology of trials using a problem-based learning approach.

Course objectives:

    * Clarify the fundamental principles and practice of RCTs

    * Demonstrate the optimal methodology to use in RCTs based on considerable practical experience and using extensive examples from the literature

    * Examine the critical issues involved in planning, conducting and completing a successful trial

    * Provide a basic understanding of statistical input into RCTs per se including analyses frequently used

    * Facilitate critical appraisal of RCTs

Course tutors:

  • Prof Doug Altman, Director, Centre for Statistics in Medicine, University of Oxford
  • Prof Peter Rothwell, Director, Oxford Stroke Prevention Research Unit, University of Oxford
  • Prof Mike Clarke, Director, MRC All-Ireland Trials Methodology Research Hub, Queen’s University Belfast
  • Dr Jonathan Cook, University Lecturer, Nuffield Department of Orthopaedics, Rheumatology ad Musculoskeletal Sciences and Centre for Statistics in Medicine, University of Oxford.
  • Susan Dutton, Lead Statistician, Oxford Clinical Trials Research Unit and Centre for Statistics in Medicine, University of Oxford
  • Dr Vicki Barber, Oxford Clinical Trials Research Unit, University of Oxford
  • Ed Juszczak, Head of Trials, National Perinatal Epidemiology Unit, University of Oxford
  • Pollyanna Hardy, Senior Medical Statistician, National Perinatal Epidemiology Unit, University of Oxford

                                                                                   

Who should attend:

The course is aimed at persons planning or actively involved in trials, or individuals interested in furthering their knowledge of trial methodology. Applications are invited from clinical and non-clinical researchers and other professionals allied to medicine. The course provides an overview of clinical trials and would benefit persons early in their career or serve as a refresher for more experienced individuals.

Please email rct.course@csm.ox.ac.uk  for more information or to register.

Similar stories

Celebrating Clinical Trials Day at NDORMS

To mark Clinical Trials Day we take a look at some of the recent developments at NDORMS and celebrate the teams that make this important area of our research programme possible.

Breakthrough in treatment for Dupuytren’s disease

Injection of the anti-TNF drug adalimumab into Dupuytren’s disease nodules is effective in reducing nodule hardness and nodule size.

Liposomal bupivacaine found to be no more effective than current treatments for post-operative knee pain

A new study published in JAMA, has found that a drug recently licensed in the UK has no effect on post-operative knee replacement recovery or pain, compared to the current treatment when administered at site of surgery.

Cemented hip replacement improves quality of life for patients over 60

The White 5 trial compared implants fixed with bone cement against uncemented implants for hip fractures treated with hemiarthroplasty.

FUTURE-GB looking ahead to 2022

FUTURE-GB has bounced into 2022 ahead of both predicted recruitment into Stage 2 (the Randomised Controlled Trial), and the sites open in Stage 2! Congratulations to all our sites for their hard work so far.